Document:

Exhibit 10.1

 

EXECUTION
VERSION

 

SETTLEMENT
AGREEMENT

 

This
SETTLEMENT AGREEMENT (this “Agreement”) is made and entered into as of December 22, 2016, by and among Surge
Components, Inc., a Nevada corporation (the “Company”), and Ira Levy, Steven J. Lubman, Alan Plafker, Lawrence
Chariton, Gary Jacobs and Martin Novick (the “Insiders”), on the one hand, and Messrs. Michael D. Tofias and
Bradley P. Rexroad (collectively, the “Stockholders”), on the other hand.

 

RECITALS

 

WHEREAS,
as of the date hereof, Mr. Tofias beneficially owns 1,568,123 shares of the issued and outstanding common stock of the Company,
par value $0.001 per share (“Common Stock”), and Mr. Rexroad beneficially owns 680,569 shares of Common Stock;

 

WHEREAS,
on June 15, 2016, Mr. Tofias submitted a proposal to the Company for inclusion in the Company’s definitive proxy statement
(as amended, revised or supplemented through the date of this Agreement, the “Company Proxy Statement”) for
the Company’s 2016 Annual Meeting of Stockholders for fiscal year 2015 (including any adjournments, postponements or other
delays thereof, the “2016 Annual Meeting”) pursuant to Rule 14a-8 under the Exchange Act (as defined below)
that the Board of Directors of the Company (the “Board”) take all necessary steps to change the Company’s
jurisdiction of incorporation to Delaware (the “Rule 14a-8 Reincorporation Stockholder Proposal”);

 

WHEREAS,
on June 29, 2016, Mr. Rexroad submitted to the Company a proposal for inclusion in the Company Proxy Statement pursuant to Rule
14a-8 under the Exchange Act proposing that the Board take all necessary steps to eliminate the classification of the Board and
to require that all directors be elected on an annual basis (the “Rule 14a-8 Declassification Stockholder Proposal”
and, together with the Rule 14a-8 Reincorporation Stockholder Proposal, the “Rule 14a-8 Stockholder Proposals”);

 

WHEREAS,
on August 25, 2016, the Stockholders delivered a letter to the Company (the “Notice”) giving notice of their
intent to (i) nominate Messrs. Rexroad and Tofias for election to the Board at the 2016 Annual Meeting (the “Director
Nominations”); (ii) submit a stockholder proposal at the 2016 Annual Meeting that the Board take all necessary steps
to eliminate the classification of the Board and to require that all directors be elected on an annual basis (“Declassification
Stockholder Proposal”); and (iii) submit a stockholder proposal at the 2016 Annual Meeting to repeal each provision
or amendment to the Amended and Restated By-Laws of the Company (the “By-Laws”) adopted by the Board after
February 18, 2016 without the approval of stockholders (the “By-Law Amendment Proposal” and, together with
the Rule 14a-8 Reincorporation Stockholder Proposal, the Rule 14a-8 Declassification Stockholder Proposal and the Declassification
Stockholder Proposal, collectively, the “Stockholder Proposals”); and

 

WHEREAS,
on October 25, 2016, the Stockholders filed a definitive proxy statement on Schedule 14A with the SEC (as defined below) for the
purpose of soliciting proxies from the stockholders of the Company for the Director Nominations and the Stockholder Proposals.

 

     

     

    

 

NOW,
THEREFORE, in consideration of the foregoing premises and the mutual covenants and agreements contained herein, and for other
good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to
be legally bound hereby, agree as follows:

 

1.        Withdrawal
of Proxy Contest.

 

(a)       The
Stockholders hereby irrevocably withdraw (i) the Notice and (ii) the Rule 14a-8 Stockholder Proposals.

 

(b)       The
Stockholders shall, and shall cause their Representatives to, immediately cease all solicitation efforts in connection with the
2016 Annual Meeting.

 

(c)       The
Stockholders shall not, and shall not permit their Representatives to, vote, deliver or otherwise use any proxies of other stockholders
of the Company that may have been received by the Stockholders or any of their Representatives to date with respect to the 2016
Annual Meeting.

 

2.        Annual
Meeting Matters.

 

(a)       Promptly
after the date of this Agreement, the Company will engage in a customary solicitation of proxies for use at the 2016 Annual Meeting.
The Company shall hold the 2016 Annual Meeting on January 5, 2017. The only matters and proposals that the Company shall present
for a vote of the stockholders at the 2016 Annual Meeting shall be proposals Nos. 1, 2, 3 and 4 set forth in the Company Proxy
Statement.

 

(b)       The
Stockholders shall appear in person or by proxy at the 2016 Annual Meeting and be present for quorum purposes and vote all shares
of Common Stock beneficially owned by them and over which they have voting power at the 2016 Annual Meeting in accordance with
the Board’s recommendations with respect to proposals Nos. 1, 3 and 4 set forth in the Company Proxy Statement. The Stockholders
shall not execute any proxy card or voting instruction form in respect of the 2016 Annual Meeting other than the proxy card and
related voting instruction form being solicited by or on behalf of the Board. The Stockholders agree that they shall not, and
they shall not permit any of their Representatives to, directly or indirectly, take any action inconsistent with this Section
2(b).

 

(c)       The
Company shall hold the 2017 Annual Meeting of Stockholders for fiscal year 2016 (the “2017 Annual Meeting”)
no later than December 29, 2017.

 

3.        Corporate
Governance Matters.

 

(a)       Board
Matters.

 

(i)       Promptly
following the date of this Agreement, the Board and the Stockholders shall engage in good faith discussions to identify a mutually
acceptable “independent” director (the “New Director”) to join the Board as a Class C director
with a term expiring at the 2017 Annual Meeting. The Company and the Stockholders shall use their respective reasonable best efforts
to agree on the New Director prior to February 28, 2017. After the Board and the Stockholders agree on the New Director, the Company
shall take all action necessary to appoint the New Director to the Board within five (5) Business Days of such agreement. The
Board shall offer the New Director membership on each of the Board’s committees (whether existing on the date of this Agreement
or formed afterward). The Board shall include the New Director on its slate of nominees at the 2017 Annual Meeting.

 

    	 	2	 

     

    

 

(ii)       If
the Tender Offer (as defined below) is not completed on or before the Tender Offer Expiration Date (as defined below), then the
Company shall (A) within five (5) Business Days take all action necessary to (1) appoint Messrs. Rexroad and Tofias to the Board
as Class A directors with a term expiring at the Company’s 2019 Annual Meeting for fiscal year 2018 (the “2019
Annual Meeting”); and (2) reduce the size of the Board to six directors (which six directors shall be the New Director
(it being understood that if the New Director has not been identified, then the seat to be occupied by the New Director will remain
empty until the New Director is identified and joins the Board), Messrs. Tofias and Rexroad, and three directors serving on the
Board as of the Tender Offer Expiration Date); and (B) not thereafter increase the size of the Board without the prior written
consent of the Stockholders. Notwithstanding the foregoing, if (a) the Tender Offer is not completed on or before the Tender Offer
Expiration Date solely due to the failure to fulfill any of the Closing Conditions and (b) the Company used its reasonable best
efforts to satisfy the Closing Conditions on or before the Tender Offer Expiration Date and continues to use its reasonable best
efforts to satisfy the Closing Conditions thereafter, then the Company’s obligations pursuant to the first sentence of this
Section 3(a)(ii) shall be suspended until no later than 11:59 p.m., Eastern time, on May 1, 2017. If the Tender Offer has not
been completed by 11:59 p.m., Eastern time, on May 1, 2017 (regardless of whether the Closing Conditions have been or are capable
of being fulfilled) or the Company is no longer using its reasonable best efforts to satisfy the Closing Conditions, the Company’s
obligations pursuant to the first sentence of this Section 3(a)(ii) shall no longer be suspended and the Company shall, within
five (5) Business Days, comply with such obligations by, among other things, appointing Messrs. Rexroad and Tofias to the Board.
It is agreed that the appointment of Messrs. Rexroad and Tofias to the Board pursuant to this Section 3(a)(ii) shall be in addition
to, and not exclusive of, any other legal remedies that may be available to the Stockholders for the Company’s breach of
any covenant or agreement contained in this Agreement. By signing this Agreement, each of the Insiders agrees to take all action
necessary (including by resigning from the Board) to effectuate this Section 3(a)(ii).

 

(b)      Cessation
of Equity Awards. For one year from the date of this Agreement, the Company shall not make any stock grants, option grants
or any other grants of non-cash compensation (each, an “Equity Grant”) to any person who is serving as a director
or officer of the Company as of the date of this Agreement. For the avoidance of doubt, this Section 3(b) shall not prohibit the
Company from making Equity Grants to a person who first joins the Company as a director or officer after the date of this Agreement.

 

    	 	3	 

     

    

 

(c)       Reincorporation.
The Company shall take all steps necessary and within its power to change its state of incorporation from the State of Nevada
to the State of Delaware (the “Reincorporation”). The Company shall use its reasonable best efforts to make
the Reincorporation effective no later than June 30, 2017. In the furtherance of the foregoing, the Board shall (i) approve the
Reincorporation; (ii) convene a special meeting of stockholders of the Company for the purpose of approving the Reincorporation
(which purpose need not be the sole purpose of such meeting); (iii) submit to the stockholders a proposal to approve the Reincorporation
(the “Reincorporation Proposal”); (iv) recommend that stockholders of the Company vote in favor of the Reincorporation
Proposal; and (v) solicit proxies from the stockholders of the Company in support of the Reincorporation Proposal. The Insiders
and Messrs. Rexroad and Tofias shall appear in person or by proxy at the Stockholder Meeting and be present for quorum purposes
and vote, or cause to be voted, all of their shares of Common Stock in favor of the Reincorporation Proposal. The governing documents
adopted by the Company (or any successor) in connection with the Reincorporation shall be no less favorable to stockholders in
any material respect than the Company’s governing documents on the date of this Agreement.

 

(d)       Declassification.
In connection with the Reincorporation, the Company shall take all steps necessary and within its power to eliminate the classification
of the Board and to require that all directors be elected on an annual basis (the “Declassification”). The
Company shall use its reasonable best efforts to make the Declassification effective no later than June 30, 2017. The Declassification
shall occur on a “rolling” basis beginning with the first annual meeting after June 30, 2017, such that each incumbent
director as of the date of the Agreement will serve through the remainder of his three-year term, and the directors elected or
appointed at or after the date of the Agreement (other than those directors elected at the 2016 Annual Meeting) will serve one-year
terms expiring at the next annual meeting, subject to re-election, except for the directors appointed to succeed any incumbent
directors, who will finish their predecessors’ terms. In the furtherance of the foregoing, the Board shall (i) approve the
Declassification; (ii) convene a special meeting of stockholders of the Company for the purpose of approving the Declassification
(which purpose need not be the sole purpose of such meeting); (iii) submit to the stockholders a proposal to approve the Declassification
(the “Declassification Proposal”); (iv) recommend that stockholders of the Company vote in favor of the Declassification
Proposal; and (v) solicit proxies from the stockholders of the Company in support of the Declassification Proposal. The Insiders
and Messrs. Rexroad and Tofias shall appear in person or by proxy at the Stockholder Meeting and be present for quorum purposes
and vote, or cause to be voted, all of their shares of Common Stock in favor of the Declassification Proposal.

 

(e)       Auditor.
The Insiders covenant not to use Seligson & Giannattasio, LLP, the Company’s independent registered public accounting
firm, for their personal tax returns or any other matters following the conclusion of any work that Seligson & Giannattasio,
LLP is performing for the Insiders in respect of fiscal year 2016.

 

(f)       Size
of the Board. Subject to Section 3(a)(ii), until the day after the public announcement of the successful completion of the
Tender Offer, the Board will be composed of no more than seven (7) individuals.

 

    	 	4	 

     

    

 

4.        Tender
Offer.

 

(a)       The
Company shall commence (within the meaning of Rule 14d-2 under the Exchange Act), and use its reasonable best efforts to consummate,
an issuer self-tender offer to all stockholders to repurchase at least five million (5,000,000) shares of Common Stock at a price
of $1.43 per share (the “Tender Offer”) (it being understood that the Company shall not be in breach of the
foregoing in the event that less than five million (5,000,000) shares of Common Stock accept and tender in the Tender Offer).
The Tender Offer shall be completed no later than March 15, 2017 (the “Tender Offer Expiration Date”). The
obligations of the Company to accept for payment, and pay for, any shares of Common Stock tendered pursuant to the Tender Offer
shall be subject only to the satisfaction or waiver (to the extent permitted under this Agreement) of the following conditions
(the “Closing Conditions”): (A) the Company has obtained all governmental or regulatory consents and approvals
necessary in order to consummate the Tender Offer; (B) no governmental authority of competent jurisdiction has enacted, issued
or entered any restraining order, injunction or similar order or legal restraint that enjoins or otherwise prohibits the consummation
of the Tender Offer; and (C) no legal action shall have been proposed, instituted or pending by a governmental authority of competent
jurisdiction that challenges or otherwise relates to the Tender Offer. In no event shall the Company, without the prior written
consent of the Stockholders, (i) reduce the number of shares of Common Stock subject to the Tender Offer; (ii) reduce the price
per share in the Tender Offer or change the form of consideration payable pursuant to the Tender Offer; or (iii) amend or supplement
any term of the Tender Offer in a manner adverse to the Company’s stockholders.

 

(b)       Promptly
following the commencement of the Tender Offer, the Stockholders shall tender or cause to be tendered all of the shares of Common
Stock that they hold beneficially or of record in the Tender Offer. Notwithstanding the foregoing, (i) the Stockholders will be
permitted to sell any of their shares of Common Stock (including, if applicable, by withdrawing such shares from the Tender Offer)
in open-market transactions; (ii) the Stockholders may withdraw any shares of Common Stock from the Tender Offer in order to sell,
tender or exchange such shares to or with a Third Party (as defined below) at a higher per share value then the Stockholders otherwise
would receive in the Tender Offer, except that the Stockholders shall not sell any of their shares of Common Stock in non-open
market transactions to any Third Party that, to the knowledge of the Stockholders, has any beneficial ownership interest (including
beneficial ownership of the shares of Common Stock acquired by such Third Party from the Stockholders) of 5.0% or more of the
then-outstanding shares of Common Stock; and (iii) Mr. Tofias may withhold up to four hundred thousand (400,000) shares from the
Tender Offer in order to transfer them to organizations that are (A) tax-exempt under section 501(c)(3) of the Internal Revenue
Code and (B) unaffiliated with Mr. Tofias.

 

(c)       Each
of the Insiders shall refrain, and shall cause its Affiliates to refrain, from tendering any shares of Common Stock that they
own beneficially or of record in the Tender Offer. The Company shall not accept, and shall cause its Representatives not to accept,
any shares of Common Stock from the Insiders or their Affiliates in the Tender Offer. The Insiders shall not, and shall cause
their Affiliates not to, transfer (except as may be specifically required by a final, non-appealable order of a court of competent
jurisdiction or by operation of applicable law), sell, exchange, pledge or otherwise dispose of any shares of Common Stock from
the date hereof until six months after the Tender Offer is completed (as reflected in filings made by the Company with the SEC);
provided, however, that the foregoing shall not apply to transfers (i) to Affiliates of such Insider (but only to
the extent that any such Affiliate signs a joinder to this Agreement reasonably acceptable to the Stockholders) or (ii) by an
individual, either during his lifetime or upon death, by will or intestacy, or to any trust, limited partnership, limited liability
company or other entity established for the primary benefit of any of the Insider or his siblings, ancestors, descendants or spouse
for estate planning purposes.

 

    	 	5	 

     

    

 

(d)       The
Company shall comply with all laws, rules and regulations in connection with the Tender Offer.

 

5.        Standstill.
Except as otherwise provided in this Agreement, without the prior written consent of the Board, the Stockholders shall not, and
shall instruct their Representatives not to, directly or indirectly (in each case, except as permitted by this Agreement):

 

(a)       (i)
acquire, offer or agree to acquire, or acquire rights to acquire (except by way of stock dividends or other distributions or offerings
made available to holders of voting securities of the Company generally on a pro rata basis), whether by purchase, tender or exchange
offer, through the acquisition of control of another person, by joining a group, through swap or hedging transactions or otherwise,
any voting securities of the Company or any voting rights decoupled from the underlying voting securities; or (ii) knowingly sell,
offer or agree to sell, through swap or hedging transactions or otherwise, the voting securities of the Company or any voting
rights decoupled from the underlying voting securities held by the Stockholders to any Third Party that would result in such Third
Party having any beneficial ownership interest of 5.0% or more of the then-outstanding shares of Common Stock (except for Schedule
13G filers that are mutual funds, pension funds or index funds with no known history of activism);

 

(b)       (i)
nominate or recommend for nomination a person for election at any Stockholder Meeting at which the Company’s directors are
to be elected; (ii) initiate, knowingly encourage or participate in any solicitation of proxies in respect of any election contest
or removal contest with respect to the Company’s directors; (iii) submit any stockholder proposal for consideration at,
or bring any other business before, any Stockholder Meeting; (iv) initiate, knowingly encourage or participate in any solicitation
of proxies in respect of any stockholder proposal for consideration at, or other business brought before, any Stockholder Meeting:
(v) knowingly encourage or participate in any request to call a special meeting of the stockholders of the Company; or (vi) initiate,
knowingly encourage or participate in any “withhold” or similar campaign with respect to any Stockholder Meeting;
provided, however, that, except as set forth in Section 2(b) or Section 3, nothing in this Section 5(b) will be
interpreted to restrict the Stockholders’ ability to (A) privately recommend candidates for the Board or (B) vote their
shares on any proposal duly brought before the Company’s stockholders as each Stockholder determines in his sole discretion;

 

(c)       form,
join or in any way participate in any group with respect to any voting securities of the Company in connection with any election
or removal contest with respect to the Company’s directors (other than with the Stockholders or one or more of their Affiliates
to the extent that any such person signs a joinder to this Agreement reasonably acceptable to the Company);

 

(d)       deposit
any voting securities of the Company in any voting trust or subject any Company voting securities to any arrangement or agreement
with respect to the voting thereof, other than any such voting trust, arrangement or agreement solely among the Stockholders and
one or more of their Affiliates;

 

    	 	6	 

     

    

 

(e)       seek
publicly, alone or in concert with others, to amend any provision of the Company’s articles of incorporation or bylaws;

 

(f)       demand
an inspection of the Company’s books and records;

 

(g)      effect
or seek to effect, offer or propose to effect, cause or participate in, or in any way knowingly assist or facilitate any other
person to effect or seek, offer or propose to effect or participate in, any (i) acquisition of any securities, or any material
assets or businesses, of the Company or any of its subsidiaries; (ii) tender offer or exchange offer (except as specifically contemplated
by this Agreement), merger, acquisition, share exchange or other business combination involving any of the voting securities or
any of the material assets or businesses of the Company or any of its subsidiaries; or (iii) recapitalization, restructuring,
liquidation, dissolution or other extraordinary transaction with respect to the Company or any of its subsidiaries or any material
portion of its or their businesses;

 

(h)      enter
into any discussions, negotiations, agreements or understandings with any Third Party with respect to the foregoing, or advise,
assist, encourage or seek to persuade any Third Party to take any action with respect to any of the foregoing, or otherwise take
or cause any action inconsistent with any of the foregoing; or

 

(i)       take
any action challenging the validity or enforceability of this Section 5 or this Agreement, or publicly make or in any way advance
publicly any request or proposal that the Company or the Board amend, modify or waive any provision of this Agreement.

 

6.        Mutual
Non-Disparagement. No party hereto shall, and no party shall permit any of its Representatives to, publicly disparage or publicly
criticize any other party or its subsidiaries, its or its subsidiaries’ business or any of its or its subsidiaries’
current or former directors, officers or employees, including the business and current or former directors, officers and employees
of such other party’s Affiliates, as applicable. The restrictions in this Section 6 shall not (i) apply (A) in any compelled
testimony or production of information, whether by legal process, subpoena or as part of a response to a request for information
from any governmental or regulatory authority with jurisdiction over the party from whom information is sought, in each case,
to the extent required; or (B) to any disclosure required by applicable law, rules or regulations; or (ii) prohibit any person
from reporting possible violations of federal law or regulation to any governmental authority pursuant to Section 21F of the Exchange
Act or Rule 2F promulgated thereunder. Notwithstanding anything to the contrary in this Agreement, the Stockholders will not be
in violation of this Agreement if they privately disclose how they intend to vote their shares of Common Stock at any Stockholder
Meeting.

 

7.        Withdrawal
of Litigation.

 

(a)       Promptly
following the date hereof, the Stockholders shall withdraw with prejudice their Legal Proceeding Case No. A-16-745893-B (the “Nevada
Lawsuit”) against the Company and its directors in Clark County, Nevada.

 

    	 	7	 

     

    

 

(b)      The
Stockholders covenant and agree that they shall not, and shall not permit any of their Representatives to, alone or in concert
with others, knowingly encourage or pursue, or knowingly assist any other person to threaten, initiate or pursue, any lawsuit,
claim or proceeding before any court or governmental, administrative or regulatory body (collectively, “Legal Proceeding”)
against the Company or any of its Representatives, except for any Legal Proceeding initiated solely to remedy a breach of or to
enforce this Agreement; provided, however, that the foregoing shall not prevent the Stockholders or any of their
Representatives from responding to oral questions, interrogatories, requests for information or documents, subpoenas, civil investigative
demands or similar processes (a “Legal Requirement”) in connection with any Legal Proceeding if such Legal
Proceeding has not been initiated by, or on behalf of, the Stockholders or any of their Representatives; provided, further,
that in the event that any of the Stockholders or any of their Representatives receives such Legal Requirement, the Stockholders
shall give prompt written notice of such Legal Requirement to the Company.

 

(c)       The
Company and the Insiders each covenant and agree that it shall not, and shall not permit any of its Representatives to, alone
or in concert with others, knowingly encourage or pursue, or knowingly assist any other person to threaten, initiate or pursue,
any Legal Proceedings against Messrs. Tofias or Rexroad or any of their respective Representatives, except for any Legal Proceeding
initiated solely to remedy a breach of or to enforce this Agreement; provided, however, that the foregoing shall
not prevent the Company, any Insider or any of its respective Representatives from responding to a Legal Requirement in connection
with any Legal Proceeding if such Legal Proceeding has not been initiated by, or on behalf of, the Company, any Insider or any
of its respective Representatives; provided, further, that in the event the Company, any Insider or any of its respective
Representatives receives such Legal Requirement, the Company shall give prompt written notice of such Legal Requirement to the
Stockholders.

 

8.        Mutual
Releases.

 

(a)       Each
of the Stockholders, on behalf of themselves and their respective heirs, estates, trustees, beneficiaries, successors, predecessors,
assigns, subsidiaries, principals, directors, officers, insurers, Associates and Affiliates (the “Stockholder Releasors”),
hereby do remise, release and forever discharge, and covenant not to sue or take any steps to pursue or further any Legal Proceeding
against, the Company or its successors, predecessors, assigns, subsidiaries, principals, directors, officers, insurers, Associates
and Affiliates (the “Company Releasees”), and each of them, from and in respect of any and all claims and causes
of action, whether based on any federal, state or foreign law or right of action, direct, indirect or representative in nature,
foreseen or unforeseen, matured or unmatured, known or unknown, that all or any of the Stockholder Releasors have, had or may
have against the Company Releasees, or any of them, of any kind, nature or type whatsoever, from the beginning of time to the
date of this Agreement; provided, however, that the foregoing release shall not release any rights or duties under
this Agreement or any claims or causes of action that the Stockholder Releasors may have for the breach or enforcement of any
provision of this Agreement.

 

    	 	8	 

     

    

 

(b)      The
Company and the Insiders, each on behalf of itself and its successors, predecessors, assigns, subsidiaries, principals, directors,
officers, insurers, Associates and Affiliates (the “Company Releasors”), hereby do remise, release and forever
discharge, and covenant not to sue or take any steps to pursue or further any Legal Proceeding against, any of the Stockholders
or their respective heirs, estates, trustees, beneficiaries, successors, predecessors, assigns, subsidiaries, principals, directors,
officers, insurers, Associates and Affiliates (the “Stockholder Releasees”), and each of them, from and in
respect of any and all claims and causes of action, whether based on any federal, state or foreign law or right of action, direct,
indirect or representative in nature, foreseen or unforeseen, matured or unmatured, known or unknown, that all or any of the Company
Releasors have, had or may have against the Stockholder Releasees, or any of them, of any kind, nature or type whatsoever, from
the beginning of time to the date of this Agreement; provided, however, that the foregoing release shall not release
any rights or duties under this Agreement or any claims or causes of action that the Company Releasors may have for the breach
or enforcement of any provision of this Agreement.

 

(c)       Each
party hereto represents and warrants that it has not heretofore transferred or assigned, or purported to transfer or assign, to
any person, firm or corporation any claims, demands, obligations, losses, causes of action, damages, penalties, costs, expenses,
attorneys’ fees, liabilities or indemnities herein released. Other than for the Nevada Lawsuit, each of the parties hereto
represents and warrants that neither it nor any assignee has filed any lawsuit against any other party.

 

(d)       Each
party hereto waives any and all rights (to the extent permitted by state law, federal law, principles of common law or any other
law) that may have the effect of limiting the releases in this Section 8. Without limiting the generality of the foregoing, each
party hereto acknowledges that there is a risk that the damages and costs that it believes it has suffered or will suffer may
turn out to be other than or greater than those now known, suspected or believed to be true. Facts on which each party hereto
has been relying in entering into this Agreement may later turn out to be other than or different from those now known, suspected
or believed to be true. Each party hereto acknowledges that in entering into this Agreement, it has expressed that it agrees to
accept the risk of any such possible unknown damages, claims, facts, demands, actions and causes of action. Each party hereto
acknowledges and agrees that the releases and covenants provided for in this Section 8 are binding, unconditional and final as
of the date hereof.

 

9.        Press
Release and SEC Filings.

 

(a)       No
later than one Business Day following the date of this Agreement, the Company shall announce the entry into this Agreement and
the material terms hereof by means of a mutually agreed upon press release in the form attached hereto as Exhibit A (the
“Mutual Press Release”). Prior to the issuance of the Mutual Press Release, neither the Company nor the Stockholders
shall issue any press release, public announcement or other public statement (including, without limitation, in any filing required
under the Exchange Act) regarding this Agreement or take any action that would require public disclosure thereof without the prior
written consent of the Other Party. No party hereto or any of its Representatives shall issue any press release, public announcement
or other public statement (including, without limitation, in any filing required under the Exchange Act) concerning the subject
matter of this Agreement inconsistent with the Mutual Press Release, except as required by law or applicable stock exchange listing
rules or with the prior written consent of the Other Party and otherwise in accordance with this Agreement.

 

    	 	9	 

     

    

 

(b)      No
later than two Business Days following the date of this Agreement, the Stockholders shall file with the SEC an amendment to their
Schedule 13D in compliance with Section 13 of the Exchange Act reporting their entry into this Agreement, disclosing applicable
items to conform to their obligations hereunder and appending this Agreement as an exhibit thereto (the “Schedule 13D
Amendment”). The Schedule 13D Amendment shall be consistent with the Mutual Press Release and the terms of this Agreement.
The Stockholders shall provide the Company and its Representatives with a reasonable opportunity to review the Schedule 13D Amendment
prior to it being filed with the SEC and consider in good faith any comments of the Company and its Representatives.

 

(c)       No
later than four Business Days following the date of this Agreement, the Company shall file with the SEC a Current Report on Form
8-K reporting its entry into this Agreement, disclosing applicable items to conform to its obligations hereunder and appending
this Agreement and the Mutual Press Release as an exhibit thereto (the “Form 8-K”). The Form 8-K shall be consistent
with the Mutual Press Release and the terms of this Agreement. The Company shall provide the Stockholders and their Representatives
with a reasonable opportunity to review and comment on the Form 8-K prior to the filing with the SEC and consider in good faith
any comments of the Stockholders.

 

(d)      The
Company shall provide the Stockholders and their Representatives with a reasonable opportunity to review and comment on the documents
for the Tender Offer prior to them being filing with the SEC and consider in good faith any comments of the Stockholders.

 

10.      Compliance
with Securities Laws. Each of the Stockholders acknowledges that the U.S. securities laws generally prohibit any person who
has received from an issuer material, non-public information concerning such issuer from purchasing or selling securities of such
issuer and from communicating such information to any other person under circumstances in which it is reasonably foreseeable that
such person is likely to purchase or sell such securities.

 

11.      Affiliates
and Associates. Each party hereto shall cause their Affiliates and Associates to comply with the terms of this Agreement and
shall be responsible for any breach of this Agreement by any such Affiliate or Associate. A breach of this Agreement by an Affiliate
or Associate of a party, if such Affiliate or Associate is not a party to this Agreement, shall be deemed to occur if such Affiliate
or Associate engages in conduct that would constitute a breach of this Agreement if such Affiliate or Associate was a party to
the same extent as the first party.

 

12.       Representations
and Warranties.

 

(a)      Each
Stockholder severally and not jointly represents and warrants as to himself that he is sui juris and of full capacity.
Each Stockholder severally and not jointly represents and warrants as to himself that he has full power and authority to execute,
deliver and carry out the terms and provisions of this Agreement and to consummate the transactions contemplated hereby, and that
this Agreement has been duly and validly executed and delivered by such Stockholder, constitutes a valid and binding obligation
and agreement of such Stockholder and is enforceable against such Stockholder in accordance with its terms. Mr. Tofias represents
and warrants that, as of the date of this Agreement, he beneficially owns 1,568,123 shares of Common Stock, has voting authority
over such shares, and owns no Synthetic Equity Interests or any Short Interests in the Company. Mr. Rexroad represents and warrants
that, as of the date of this Agreement, he beneficially owns 680,569 shares of Common Stock, has voting authority over such shares,
and owns no Synthetic Equity Interests or any Short Interests in the Company. The Stockholders represent and warrant that, except
with themselves, they have not formed and are not members of any group with any other person and are not acting in concert with
any other person.

 

    	 	10	 

     

    

 

(b)      The
Company hereby represents and warrants that it has the power and authority to execute, deliver and carry out the terms and provisions
of this Agreement and to consummate the transactions contemplated hereby, and that this Agreement has been duly and validly authorized,
executed and delivered by the Company, constitutes a valid and binding obligation and agreement of the Company, is enforceable
against the Company in accordance with its terms and does not require the approval of the Company’s stockholders. The Company
hereby represents and warrants that there are no governmental or regulatory consents or approvals necessary in order to consummate
the Tender Offer, except for necessary filings with the SEC. The Company hereby represents and warrants that, at the date hereof,
the Company has deferred tax assets attributable to net operating losses of approximately $10,035,996. The Company has, and will
have at the closing of the Tender Offer, sufficient cash, available lines of credit or other sources of immediately available
funds to enable it to pay the aggregate amounts contemplated by the Tender Offer and to perform its obligations under this Agreement.

 

(c)      Each
Insider severally and not jointly represents and warrants that he is sui juris and of full capacity. Each Insider severally
and not jointly represents and warrants that he has full power and authority to execute, deliver and carry out the terms and provisions
of this Agreement and to consummate the transactions contemplated hereby, and that this Agreement has been duly and validly executed
and delivered by such Insider, constitutes a valid and binding obligation and agreement of such Insider and is enforceable against
such Insider in accordance with its terms.

 

13.      Termination.
This Agreement shall terminate on the date that is 15 Business Days prior to the deadline under the By-Laws for director nominations
and stockholder proposals for the 2019 Annual Meeting (such date, the “Termination Date”). No termination shall
relieve any party hereto from liability for any breach of this Agreement prior to such termination. Notwithstanding anything to
the contrary in this Agreement:

 

(a)      The
obligations of the Stockholders pursuant to Section 1, Section 2, Section 3, Section 4, Section 5, Section 6, Section 7, Section
9 and Section 11 shall terminate (i) in connection with Messrs. Rexroad and Tofias joining the Board pursuant to Section 3(a)(ii);
or (ii) in the event that the Company materially breaches its obligations pursuant to Section 2, Section 3, Section 4, Section
5, Section 6, Section 7, Section 9 or the representations and warranties in Section 12(b) of this Agreement and, in each case,
such breach has not been cured within 30 days following written notice of such breach; provided, however, that any
termination in respect of a breach of Section 6 shall require a determination of a court of competent jurisdiction that the Company
has materially breached Section 6; provided, further, that the obligations of the Stockholders pursuant to Section
7 shall terminate immediately in the event that the Company materially breaches its obligations under Section 7;

 

    	 	11	 

     

    

 

(b)      The
obligations of the Company pursuant to Section 2, Section 3, Section 4, Section 5, Section 6, Section 7, Section 9 and Section
11 shall terminate in the event that the Stockholders materially breach their obligations in Section 1, Section 2, Section 3,
Section 4, Section 5, Section 6, Section 7, Section 9, Section 11 or the representations and warranties in Section 12(a) and,
in each case, such breach has not been cured within 30 days following written notice of such breach; provided, however,
that any termination in respect of a breach of Section 6 shall require a determination of a court of competent jurisdiction that
Messrs. Tofias or Rexroad has materially breached Section 6; provided, further, that the obligations of the Company
pursuant to Section 7 shall terminate immediately in the event that Messrs. Tofias and Rexroad materially breaches its obligations
under Section 7; and

 

(c)      in
the event that the Company materially breaches its representations and warranties in the penultimate sentence of Section 12(b)
of this Agreement, the Company shall, within five (5) Business Days, take all actions necessary to cause the expiration of the
Rights Agreement, dated as of October 7, 2016, by and between the Company and Continental Stock Transfer & Trust Company.

 

14.      Expenses.
Within five Business Days following the date of this Agreement, the Company shall reimburse the Stockholders, in an amount not
to exceed $300,000, for expenses incurred by them in connection with their investment in the Company, including, but not limited
to, legal and other advisory costs, proxy solicitation costs, filing costs, and all costs incurred to mail proxy soliciting materials,
letters, and press releases to stockholders of the Company, litigation costs, and travel costs.

 

    	 	12	 

     

    

 

15.       Notices.
All notices, demands and other communications to be given or delivered under or by reason of the provisions of this Agreement
shall be in writing and shall be deemed to have been given (a) when delivered by hand, with written confirmation of receipt; (b)
upon sending if sent by facsimile to the facsimile numbers below, with electronic confirmation of sending; (c) one day after being
sent by a nationally recognized overnight carrier to the addresses set forth below; or (d) when actually delivered if sent by
any other method that results in delivery, with written confirmation of receipt:

 

	If
        to the Company or any of the Insiders:

                                                                      

        Surge
        Components, Inc.

        95
        East Jefryn Blvd.

        Dear
        Park, NY 11729

        Attention:
        Ira Levy

        Facsimile:
        (631) 595-1283

         
	with
        copies (which shall not constitute notice) to:

                                                                      

        Vinson
        & Elkins L.L.P.

        666
        Fifth Avenue, 26th Floor

        New
        York, NY 10103-0040

        Attention:
        Kai H. Liekefett

        Facsimile:
        (212) 237-0100

         

        and

         

        Ellenoff
        Grossman & Schole LLP

        1345
        Avenue of the Americas

        New
        York, NY 10105

        Attention:
        Barry I. Grossman

        Facsimile:
        (212) 370-7889

	 	 
	If
        to Michael D. Tofias:

                                                          

        Michael
        D. Tofias

        25
        Cambridge Drive

        Short
        Hills, NJ 07078

         
	with
        copies (which shall not constitute notice) to:

                                                          

        Wilson
        Sonsini Goodrich & Rosati

        Professional
        Corporation

        650
        Page Mill Road

        Palo
        Alto, CA 94304

        Attention:
        Douglas K. Schnell

        Facsimile:
        (650) 493-6811

	 	 
	If
        to Bradley P. Rexroad:

                                                          

        Bradley
        P. Rexroad

        970
        Reserve Drive, Suite 126

        Roseville,
        CA 95678
	 

 

16.       Governing
Law; Jurisdiction; Jury Waiver. This Agreement, and any disputes arising out of or related to this Agreement (whether for
breach of contract, tortious conduct or otherwise), shall be governed by, and construed in accordance with, the laws of the State
of New York, without giving effect to its conflict of laws principles. The parties hereto agree that exclusive jurisdiction and
venue for any Legal Proceeding arising out of or related to this Agreement shall exclusively lie in any state or federal court
located in the Borough of Manhattan in the State of New York. Each party hereto waives any objection it may now or hereafter have
to the laying of venue of any such Legal Proceeding, and irrevocably submits to personal jurisdiction in any such court in any
such Legal Proceeding and hereby further irrevocably and unconditionally waives and agrees not to plead or claim in any court
that any such Legal Proceeding brought in any such court has been brought in any inconvenient forum. Each party hereto consents
to accept service of process in any such Legal Proceeding by service of a copy delivered to it by certified or registered mail,
postage prepaid, return receipt requested, addressed to it at the address set forth in Section 15. Nothing contained herein shall
be deemed to affect the right of any party hereto to serve process in any manner permitted by law. EACH PARTY HERETO HEREBY IRREVOCABLY
WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT. No party hereto
shall seek to consolidate, by counterclaim or otherwise, any action in which a jury trial has been waived with any other action
in which a jury trial cannot be or has not been waived.

 

    	 	13	 

     

    

 

17.       Specific
Performance. The Stockholders, on the one hand, and the Company and the Insiders, on the other hand, acknowledge and agree
that irreparable injury to the other party would occur in the event that any provision of this Agreement were not performed in
accordance with such provision’s specific terms or were otherwise breached or threatened to be breached, and that such injury
would not be adequately compensable by the remedies available at law (including the payment of money damages). It is accordingly
agreed that the Stockholders, on the one hand, and the Company and the Insiders, on the other hand (as applicable, the “Moving
Party”), shall each be entitled to specific enforcement of, and injunctive relief to prevent any violation of, the terms
hereof, and the other party shall not take action in opposition to the Moving Party seeking such relief on the grounds that any
other remedy or relief is available at law or in equity. The party hereto against whom specific performance is sought agrees to
waive any applicable right or requirement that a bond be posted. This Section 15 shall not be the exclusive remedy for any violation
of this Agreement.

 

18.       Certain
Definitions and Interpretations. As used in this Agreement: (a) the terms “Affiliate” and “Associate”
(and any plurals thereof) have the meanings ascribed to such terms under Rule 12b-2 promulgated by the SEC under the Exchange
Act and shall include all persons or entities that at any time prior to the Termination Date become Affiliates or Associates of
any person or entity referred to in this Agreement; (b) the term “Annual Meeting” means each annual meeting
of stockholders of the Company and any adjournment, postponement, reschedulings or continuations thereof; (c) the term “Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder; (d) the
terms “beneficial ownership,” “group,” “person,” “proxy,”
and “solicitation” (and any plurals thereof) have the meanings ascribed to such terms under the Exchange Act;
(e) the term “Business Day” means any day that is not a Saturday, Sunday or other day on which commercial banks
in the State of New York are authorized or obligated to be closed by applicable law; (f) the term “Other Party”
means (i) with respect to the Company, Mr. Tofias or Mr. Rexroad, and (ii) with respect to Mr. Tofias or Mr. Rexroad, the Company;
(g) the term “Representatives” means a person’s Affiliates and Associates and its and their respective
directors, officers, employees, partners, members, managers, consultants, legal or other advisors, agents and other representatives;
(h) the term “SEC” means the U.S. Securities and Exchange Commission; (i) the term “Short Interests”
means any agreement, arrangement, understanding or relationship, including any repurchase or similar so-called “stock borrowing”
agreement or arrangement, engaged in by such person, the purpose or effect of which is to mitigate loss to, reduce the economic
risk (of ownership or otherwise) of shares of any class or series of the Company’s equity securities by, manage the risk
of share price changes for, or increase or decrease the voting power of, such person with respect to the shares of any class or
series of the Company’s equity securities, or that provides the opportunity to profit from any decrease in the price or
value of the shares of any class or series of the Company’s equity securities; (j) the term “Stockholder Meeting”
means each annual or special meeting of stockholders of the Company, or any other meeting of stockholders held in lieu thereof,
and any adjournment, postponement, reschedulings or continuations thereof; (k) the term “Synthetic Equity Interests”
means any derivative, swap or other transaction or series of transactions engaged in by such person, the purpose or effect of
which is to give such person economic risk similar to ownership of equity securities of any class or series of the Company, including
due to the fact that the value of such derivative, swap or other transactions are determined by reference to the price, value
or volatility of any shares of any class or series of the Company’s equity securities, or which derivative, swap or other
transactions provide the opportunity to profit from any increase in the price or value of shares of any class or series of the
Company’s equity securities, without regard to whether (i) the derivative, swap or other transactions convey any voting
rights in such equity securities to such person; (ii) the derivative, swap or other transactions are required to be, or are capable
of being, settled through delivery of such equity securities; or (iii) such person may have entered into other transactions that
hedge or mitigate the economic effect of such derivative, swap or other transactions; and (l) the term “Third Party”
refers to any person that is not a party hereto, a member of the Board, a director or officer of the Company, or legal counsel
to any party. In this Agreement, unless a clear contrary intention appears, (i) the word “including” (in its various
forms) means “including, without limitation;” (ii) the words “hereunder,” “hereof,” “hereto”
and words of similar import are references in this Agreement as a whole and not to any particular provision of this Agreement;
(iii) the word “or” is not exclusive; and (iv) references to “Sections” in this Agreement are references
to Sections of this Agreement unless otherwise indicated.

 

    	 	14	 

     

    

 

19.       Miscellaneous.

 

(a)       This
Agreement contains the entire agreement and supersedes all prior agreements and understandings, both written and oral, between
the parties hereto with respect to the subject matter hereof.

 

(b)       This
Agreement is solely for the benefit of the parties hereto and is not enforceable by any other persons.

 

(c)       This
Agreement shall not be assignable by operation of law or otherwise by a party hereto without the consent of the other parties.
Any purported assignment without such consent is void. Subject to the foregoing sentence, this Agreement shall be binding upon,
inure to the benefit of, and be enforceable by and against the permitted successors and assigns of each party hereto.

 

(d)       Neither
the failure nor any delay by a party hereto in exercising any right, power or privilege under this Agreement shall operate as
a waiver thereof, nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise
of any right, power or privilege hereunder.

 

(e)       If
any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, void
or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Agreement shall remain in full force
and effect and shall in no way be affected, impaired or invalidated. It is hereby stipulated and declared to be the intention
of the parties hereto that the parties would have executed the remaining terms, provisions, covenants and restrictions without
including any of such which may be hereafter declared invalid, void or unenforceable. In addition, the parties hereto agree to
use their reasonable best efforts to agree upon and substitute a valid and enforceable term, provision, covenant or restriction
for any of such that is held invalid, void or enforceable by a court of competent jurisdiction.

 

    	 	15	 

     

    

 

(f)       Any
amendment or modification of the terms and conditions set forth herein or any waiver of such terms and conditions must be agreed
to in a writing signed by each party hereto.

 

(g)       This
Agreement may be executed in one or more textually identical counterparts, each of which shall be deemed an original, but all
of which together shall constitute one and the same agreement. Signatures to this Agreement transmitted by facsimile transmission,
by electronic mail in “portable document format” (“.pdf”) form, or by any other electronic means intended
to preserve the original graphic and pictorial appearance of a document, shall have the same effect as physical delivery of the
paper document bearing the original signature.

 

(h)       Each
of the parties hereto acknowledges that it has been represented by counsel of its choice throughout all negotiations that have
preceded the execution of this Agreement, and that it has executed this Agreement with the advice of such counsel. Each party
hereto and its counsel cooperated and participated in the drafting and preparation of this Agreement, and any and all drafts relating
thereto exchanged among the parties will be deemed the work product of all of the parties and may not be construed against any
party by reason of its drafting or preparation. Accordingly, any rule of law or any legal decision that would require interpretation
of any ambiguities in this Agreement against any party hereto that drafted or prepared it is of no application and is hereby expressly
waived by each of the parties, and any controversy over interpretations of this Agreement will be decided without regard to events
of drafting or preparation.

 

(i)       The
headings set forth in this Agreement are for convenience of reference purposes only and will not affect or be deemed to affect
in any way the meaning or interpretation of this Agreement or any term or provision of this Agreement

 

[Signature
Pages Follow]

 

    	 	16	 

     

    

 

IN
WITNESS WHEREOF, each of the parties has executed this Agreement, or caused the same to be executed by its duly authorized representative,
as of the date first above written.

 

	SURGE
    COMPONENTS, INC.	 
	 	 	 
	By:	/s/
    Ira Levy	 
	Name:	Ira
    Levy	 
	Title:	CEO,
    CFO, President and Director	 

 

Signature
Page to Settlement Agreement

 

     

     

    

 

	MICHAEL
    D. TOFIAS	 
	 	 
	/s/
    Michael D. Tofias	 
	Michael
    D. Tofias	 

 

Signature
Page to Settlement Agreement

 

     

     

    

 

	BRADLEY
    P. REXROAD	 
	 	 
	/s/
    Bradley P. Rexroad	 
	Bradley
    P. Rexroad	 

 

Signature
Page to Settlement Agreement

 

     

     

    

 

	 IRA
    LEVY	 
	 	 
	/s/
    Ira Levy 	 
	Ira
    Levy	 

 

Signature
Page to Settlement Agreement

 

     

     

    

 

	STEVEN
    J. LUBMAN	 
	 	 
	/s/
    Steven J. Lubman	 
	Steven
    J. Lubman	 

 

Signature
Page to Settlement Agreement

 

     

     

    

  

	LAWRENCE
    CHARITON	 
	 	 
	/s/
    Lawrence Chariton	 
	Lawrence
    Chariton	 

 

Signature
Page to Settlement Agreement

 

     

     

    

 

	GARY
    JACOBS	 
	 	 
	/s/
    Gary Jacobs	 
	Gary
    Jacobs	 

 

Signature
Page to Settlement Agreement

 

     

     

    

  

	ALAN
    PLAFKER	 
	 	 
	/s/
    Alan Plafker	 
	Alan
    Plafker	 

 

Signature
Page to Settlement Agreement

 

     

     

    

 

	MARTIN
    NOVICK	 
	 	 
	/s/
    Martin Novick	 
	Martin
    Novick	 

 

Signature
Page to Settlement Agreement

 

     

     

    

 

Exhibit
A

 

Mutual
Press ReleaseExhibit 10.1

 

EXECUTION VERSION

 

INDEPENDENT DIRECTOR'S AGREEMENT

 

This INDEPENDENT
DIRECTOR'S AGREEMENT (the "Agreement") is made as of December 23, 2016, by and between FORM Holdings Corp.,
a Delaware corporation (hereinafter referred to as the "Company"), and Andrew R. Heyer (the "Director").

 

BACKGROUND

 

WHEREAS, the
Board of Directors of the Company (the "Board of Directors") desires to appoint the Director to perform the duties
of an "independent" director (within the meaning of the rules of the U.S. Securities and Exchange Commission (the "SEC"))
and, potentially in the future, on committees of the Board of Directors, and the Director desires to be so appointed for such position(s)
and to perform the duties required of such position(s) in accordance with the terms and conditions of this Agreement.

 

WHEREAS, the
Director has been elected by the holders of the Company’s Series D Preferred Stock, in accordance with the terms of the Company’s
certificate of incorporation, as amended from time to time.

 

AGREEMENT

 

NOW, THEREFORE,
in consideration for the above recited premises and the mutual promises contained herein, and for other good and valuable consideration,
the adequacy and sufficiency of which are hereby acknowledged, the Company and the Director hereby agree as follows:

 

1.        DUTIES.
 The Company requires that the Director be available to perform the duties customarily related to an independent director
as may be determined and assigned by the Board of Directors and as may be required by the Company's constituent instruments, including
its certificate of incorporation, by-laws and its corporate governance and board committee charters, each as amended or modified
from time to time, and by applicable law, including, without limitation, the Delaware General Corporation Law (the "DGCL")
and the rules and regulations of the SEC, any exchange or quotation system on which the Company's securities may be traded from
time to time and all other applicable legal or regulatory requirements. Initially, the Company and the Director have agreed that
the Director will serve as a member of the Audit Committee and the Compensation Committee, effective immediately. The Director
agrees to use commercially reasonable efforts to devote as much time as is necessary to perform the duties as an independent director
in accordance with such Company requirements, including duties as a member of committees of the Board of Directors as the same
may be established from time to time. The Director will use commercially reasonable efforts to attend meetings of the Board of
Directors and its committees as the Director may be appointed to, in person or by teleconference. The Director will perform such
duties described herein in accordance with the fiduciary duties of directors arising under the DGCL.

 

2.        TERM.
The term of this Agreement shall commence as of the date hereof and shall continue until the Director’s successor is elected
and qualified or until his earlier death, incapacity, removal or resignation. The Board of Directors or a designated committee
thereof shall have the discretion to nominate or decline to nominate the Director for election at each annual or applicable special
meeting of the Company's stockholders (subject to the provisions of the Company’s constituent documents, including the terms
of the Company’s Series D Preferred Stock), and the failure to nominate the Director as, if and when such nominations are
made shall be deemed a termination of this Agreement for purposes of Section 8 hereof.

 

     

     

    

 

3.
       COMPENSATION. Subject to the approvals by the Compensation Committee or the
Board of Directors, for all duties and services to be performed by the Director hereunder, the Director will be entitled to
earn cash fees under guidelines and rules established by the Company from time to time for compensating non-employee
directors for serving on, and attending meetings of, committees of its Board of Directors and the boards of directors of its
subsidiaries. In addition to the cash fees described above, the Company may grant the Director options to purchase or
restricted shares of the Company's common stock (collectively, the "Shares") under the Company's director
compensation plans adopted from time to time. No registration rights are hereby granted with respect to the Shares.

 

4.
       Market Stand-Off Agreement. Director agrees to be subject to Section [2.11]
(“Market Stand-off” Agreement) of the Registration Rights Agreement, dated as of August 8, 2016, as amended (the “Registration
Rights Agreement”), as if Director were an Investor thereunder.

 

5.        EXPENSES.
In addition to the compensation provided in paragraph 3 hereof, the Company will reimburse the Director for pre-approved reasonable
business related expenses incurred in good faith in the performance of the Director's duties for the Company including attending
meetings of the Board of Directors and its committees as the Director may be appointed to. Such payments shall be made by the Company
upon submission by the Director of a signed statement itemizing the expenses incurred. Such statement shall be accompanied by sufficient
documentary matter to support the expenditures.

 

6.        OTHER
AGREEMENTS.

 

(a)       CONFIDENTIAL
INFORMATION AND INSIDER TRADING. The Company and the Director each acknowledge that, in order for the intents and purposes
of this Agreement to be accomplished, the Director shall necessarily be obtaining access to certain confidential information concerning
the Company and its affairs, including, but not limited to, business methods, information systems, financial data and strategic
plans which are unique assets of the Company (as further defined below, the "Confidential Information") and that
the communication of such Confidential Information to third parties could irreparably injure the Company and its business. Accordingly,
Director agrees that, during his association with the Company and thereafter, he will treat and safeguard as confidential and secret
all Confidential Information received by him at any time and that, without the prior written consent of the Company, he will not
disclose or reveal any of the Confidential Information to any third party whatsoever or use the same in any manner except in connection
with the business of the Company and in any event in no way harmful to or competitive with the Company or its business. For purposes
of this Agreement, "Confidential Information" means any information not generally known to the public or recognized as
confidential according to standard industry practice, any trade secrets, know-how, development, manufacturing, marketing and distribution
plans and information, inventions, formulas, methods or processes, whether or not patented or patentable, pricing policies and
records of the Company (and such other information normally understood to be confidential or otherwise designated as such in writing
by the Company), all of which Director expressly acknowledges and agrees shall be confidential and proprietary information belonging
to the Company. Confidential Information will not include (i) information which was known to the Director or his agents prior to
receipt from the Company; (ii) information which is or becomes generally known other than as a result of a breach of a duty of
confidentiality by the Director; (iii) information acquired by the Director or his agents from a third party who was not bound
to an obligation of confidentiality; and (iv) disclosure required by applicable law. Upon termination of his association with the
Company, Director shall return to the Company all Confidential Information, together with any copies thereof, or certify that he
has destroyed all such documents and papers. Notwithstanding the redelivery and destruction obligations of this Section 6(a), the
Director may retain one archival copy of the Confidential Information to comply with recordkeeping or regulatory requirements;
provided, that such archival material shall remain subject to the confidentiality provisions of this Section 6(a).

  

    	 	2	 

     

    

 

Furthermore, Director
recognizes that the Company has received and in the future will receive confidential or proprietary information from third parties
subject to a duty on the Company's part to maintain the confidentiality of such information and, in some cases, to use it only
for certain limited purposes. Director agrees that Director owes the Company and such third parties, both during the term of Director’s
association with the Company and thereafter, a duty to hold all such confidential or proprietary information in the strictest confidence
and not to, except as is consistent with the Company's agreement with the third party, disclose it to any person or entity or use
it for the benefit of anyone other than the Company or such third party, unless expressly authorized to act otherwise by an officer
of the Company. In addition, Director acknowledges and agrees that Director may have access to "material non-public information"
for purposes of the federal securities laws ("Insider Information") and that the Director will abide by all securities
laws relating to the handling of and acting upon such Insider Information. Further, Director agrees to sign an acknowledgement
certifying that Director has reviewed the Company's Insider Trading Manual and understands the policies and procedures contained
therein and agrees to be bound by them.

 

Notwithstanding the
foregoing, the Director may disclose Confidential Information and other confidential information to his affiliates and his and
their respective agents, partners, attorneys, accountants, and other advisors who are subject to confidentiality obligations with
respect thereto.

 

The Company acknowledges
and agrees that the Director generally may not be permitted to disclose to the Company any confidential information related to
Director’s affiliates (including investment vehicles advised by Mistral Capital Management, LLC) and that the Director may
recuse himself without explanation from any Board of Directors discussions in which such disclosures might otherwise be required.

 

Director’s obligations
under this Section 6(a) shall terminate 12 months after he ceases to be a member of the Board of Directors.

 

(b)       Covenant
against SOLICITATION. The Director agrees that during, and for twelve (12) months after, the period in which Director
is a director of the Company, Director shall not, directly or indirectly, either alone or in association with others, without the
prior written approval of the Company, in any manner whatsoever, request, solicit, encourage or assist any employee, officer, director
or consultant of or to the Company to terminate their relationship with the Company or any of its affiliates, or join with any
of them before or after the termination by any of them of any such relationship in any direct or indirect capacity in any competing
business.

 

    	 	3	 

     

    

 

(c)       DISPARAGING
STATEMENTS. At all times during the period in which Director is a member of the Board of Directors, Director shall not either
verbally, in writing, electronically or otherwise: (i) make any derogatory or disparaging statements about the Company, any of
its affiliates, any of their respective officers, directors, employees and agents, or any of the Company's current or past customers
or employees, or (ii) make any public statement or perform or do any other act prejudicial or injurious to the reputation or goodwill
of the Company or any of its affiliates or otherwise interfere with the business of the Company or any of its affiliates; provided,
however, that nothing in this paragraph shall preclude the Director from complying with all obligations imposed by law or legal
compulsion, and provided, further, however, that nothing in this paragraph shall be deemed applicable to any testimony given by
Director in any legal or administrative proceedings.

 

At all times during
the period in which Director is a director of the Board of Directors, the Company shall not (and shall cause its officers and directors
not to) either verbally, in writing, electronically or otherwise: (i) make any derogatory or disparaging statements about the Director,
any of his affiliates, any of their respective officers, directors, employees and agents, or any of the Director's or his affiliates’
current or past customers or employees, or (ii) make any public statement or perform or do any other act prejudicial or injurious
to the reputation or goodwill of the Director or any of his affiliates or otherwise interfere with the business of the Director
or any of his affiliates; provided, however, that nothing in this paragraph shall preclude the Company (or its officers and directors)
from complying with all obligations imposed by law or legal compulsion, and provided, further, however, that nothing in this paragraph
shall be deemed applicable to any testimony given by the Company (or its officers and directors) in any legal or administrative
proceedings.

 

(d)       Enforcement.
The Director and the Company each acknowledges and agrees that the covenants contained in this Section 6 are reasonable, that valid
consideration has been and will be received and that the agreements set forth herein are the result of arms-length negotiations
between the parties hereto. The Director and the Company each recognizes that the provisions of this Section 6 are vitally important
to the continuing welfare of the other and his/its affiliates, and that any violation of this Section 6 could result in irreparable
harm to the Company and its affiliates or the Director and its affiliates, respectively, for which money damages would constitute
a totally inadequate remedy. Accordingly, in the event of any such violation by the Director or the Company, in addition to any
other remedies they may have, the Company and its affiliates or the Director and its affiliates, respectively, shall have the right
to institute and maintain a proceeding to compel specific performance thereof or to obtain an injunction or other equitable relief
restraining any action by the Director or the Company, respectively, in violation of this Section 6 without posting any bond therefor
or demonstrating actual damages, and Director or the Company, respectively, will not claim as a defense thereto that the Company
or the Director, respectively, has an adequate remedy at law or require the posting of a bond. If any of the restrictions or activities
contained in this Section 6 shall for any reason be held by a court of competent jurisdiction to be excessively broad as to duration,
geographical scope, activity or subject, such restrictions shall be construed so as thereafter to be limited or reduced to be enforceable
to the extent compatible with the applicable law; it being understood that by the execution of this Agreement the parties hereto
regard such restrictions as reasonable and compatible with their respective rights. Director and the Company each acknowledges
that injunctive relief may be granted immediately upon the commencement of any such action without notice to the other party and
in addition that the other party may recover monetary damages.

 

    	 	4	 

     

    

 

(e)       Separate
Agreement. The parties hereto further agree that the provisions of Section 6 are separate from and independent of the
remainder of this Agreement and that Section 6 is specifically enforceable by each party notwithstanding any claim made by one
party against the other. The terms of this Section 6 shall survive termination of this Agreement in accordance with its terms.

 

7.        NOTICE
OF MATERIAL CHANGE IN FINANCIAL CONDITION OF THE COMPANY.  The Company shall endeavor to notify the Director in writing,
at the earliest practicable time, of any material adverse change in the financial condition of the Company.

 

8.        TERMINATION.
 With or without cause, Director may terminate this Agreement and Director's director position with the Company at any time
upon written notice to the Company. In such event, the Company shall be obligated to pay to the Director the compensation and expenses
incurred in accordance with this Agreement due up to the date of the termination.

 

Nothing contained herein
or omitted herefrom shall prevent the stockholders of the Company from removing Director with immediate effect at any time for
any reason or voting for or against the nomination of Director to serve as such at any annual or special meeting of the Company's
stockholders.

 

9.        INDEMNIFICATION;
INSURANCE. The Company shall indemnify, defend and hold harmless the Director, to the full extent allowed by the law of the
State of Delaware, and as provided by, or granted pursuant to the Company's Certificate of Incorporation (as amended and/or restated
from time to time) (the "COI"), By-laws (as amended and/or restated from time to time) (the "By-Laws"),
or any agreement, vote of stockholders or disinterested directors or otherwise, both as to action in the Director's official capacity
and as to action in another capacity relating to the Company's business while holding such office except for matters arising out
of the Director's gross negligence or willful misconduct. Such indemnification shall cover payment for or reimbursement of expenses
(including legal fees and expenses) to the fullest extent provided for in the COI and the By-Laws. The Company shall also enter
into the form of indemnification agreement attached hereto as Exhibit A. The Company’s compliance with the following
insurance provision shall not relieve the Company from liability under this indemnity provision.

 

The Company shall have
and maintain at its sole cost and expense throughout the term of this Agreement and for six (6) years thereafter, directors’
and officers’ insurance from a recognized insurance company for the benefit of all of its directors and executive officers.

 

10.        AMENDMENTS;
WAIVERS. No provision of this Agreement may be waived or amended except in a written instrument signed, in the case of an amendment,
by the Company and the Director or, in the case of a waiver, by the party against whom enforcement of any such waiver is sought.
No waiver of any breach with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing
waiver in the future or a waiver of any subsequent breach or a waiver of any other provision, condition or requirement hereof,
nor shall any delay or omission of either party to exercise any right hereunder in any manner impair the exercise of any such right.

 

    	 	5	 

     

    

 

11.        NOTICE.
Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement must
be in writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) within 24 hours, when
sent by electronic mail; or (iii) one (1) business day after deposit with an overnight courier service with next day delivery specified,
in each case, properly addressed to the party to receive the same. The addresses and facsimile numbers for such communications
shall be:

 

	 	If to the Company:
	 	 	 
	 	Attention: 	Chief Executive Officer
	 	Address:  	780 Third Avenue, 15th Floor
	 	 	New York, NY  10017
	 	Email:	APerlman@formholdings.com
	 	 	 
	 	With a copy (for informational purposes only) to:
	 	 	 
	 	Mintz Levin Cohn Ferris Glovsky and Popeo PC
	 	Attention:	Kenneth R. Koch, Esq.
	 	Address:	666 Third Avenue
	 	 	New York, NY  10017
	 	Email:	krkoch@mintz.com

 

If to the Director, to him at the
address listed on Exhibit B hereto.

 

or to such other address and/or to the
attention of such other Person as the recipient party has specified by written notice given to each other party five (5) days prior
to the effectiveness of such change. Written confirmation of receipt (A) given by the recipient of such notice, consent, waiver
or other communication, (B) mechanically or electronically generated by the sender's computer containing the time and date or (C)
provided by an overnight courier service, shall be rebuttable evidence of personal service, receipt by electronic mail or receipt
from an overnight courier service in accordance with clause (i), (ii) or (iii) above, respectively.

 

12.        GOVERNING
LAW AND DISPUTE RESOLUTION.  This Agreement shall be interpreted in accordance with, and the rights of the parties hereto
shall be determined by the laws of Delaware without reference to its conflicts of laws principles. Should a dispute arise between
the parties under or relating to this Agreement, each party agrees that prior to initiating any formal proceeding against the other
(except when injunctive relief is appropriate), the parties will each designate a representative for purposes of resolving the
dispute.  If the parties' representatives are unable to resolve the dispute within 14 business days, the dispute shall be
settled by mediation and then, if necessary, by arbitration under the then-current commercial arbitration rules of the American
Arbitration Association.  The location of the proceeding shall be in New York, NY. The award in any such arbitration shall
be final, binding, conclusive and not appealable. Judgment upon any award rendered by the arbitrator may be entered by any
court having jurisdiction thereof.

 

    	 	6	 

     

    

 

13.        ASSIGNMENT.
 The rights and benefits of the Company under this Agreement shall be transferable, and all the covenants and agreements hereunder
shall inure to the benefit of, and be enforceable by or against, its successors and assigns.  The duties and obligations of
the Director under this Agreement are personal and therefore the Director may not assign any right or duty under this Agreement
without the prior written consent of the Company.

 

14.       Severability.
If any provision of this Agreement shall be declared invalid or illegal, for any reason whatsoever, then, notwithstanding such
invalidity or illegality, the remaining terms and provisions of the this Agreement shall remain in full force and effect in the
same manner as if the invalid or illegal provision had not been contained herein.

 

15.       HEADINGS;
CONSTRUCTION. The section headings contained in this Agreement are for reference purposes only and shall not affect in any
way the meaning or interpretation of this Agreement. The language used in this Agreement will be deemed to be the language chosen
by the parties to express their mutual intent, and no rules of strict construction will be applied against any party.

 

16.       NO
THIRD-PARTY BENEFICIARIES. This Agreement is intended for the benefit of the parties hereto and their respective successors
and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other person or entity.

 

17.       Withholding.
The Company may withhold from any and all amounts payable under this Agreement such federal, state, local and foreign taxes as
may be required to be withheld pursuant to any applicable law or regulation.

 

18.       ENTIRE
AGREEMENT. Subject to the provisions of the DGCL and the Company's certificates of incorporation and bylaws, this Agreement
and the exhibits hereto set forth the entire agreement of the parties with respect to its subject matter and supersedes all prior
agreements, promises, covenants, arrangements, communications, representations or warranties, whether oral or written, by any officer,
employee or representative of any party to this Agreement with respect to such subject matter.

 

19.       COUNTERPARTS.
This Agreement may be executed in any number of counterparts, all of which shall be considered one and the same agreement and shall
become effective when counterparts have been signed by each party and delivered to the other party. In the event that any signature
is delivered by facsimile transmission or by an e-mail which contains a portable document format (.pdf) file of an executed signature
page, such signature page shall create a valid and binding obligation of the party executing (or on whose behalf such signature
is executed) with the same force and effect as if such signature page were an original thereof. Execution and delivery of this
Agreement by facsimile or other electronic signature is legal, valid and binding for all purposes.

 

    	 	7	 

     

    

 

20.       ACKNOWLEDGMENT.
The Company acknowledges that the Director and his affiliates are in the business of venture capital, growth equity, and private
equity investing and therefore review the business plans and related proprietary information of many enterprises, including enterprises
which may have products or services which compete directly or indirectly with those of the Company. Nothing in this Agreement shall
preclude or in any way restrict the Director or any of his affiliates from investing or participating in any particular enterprise
whether or not such enterprise has products or services which compete with those of the Company. The Company also hereby agrees
that, to the extent permitted under applicable law, the Director and his affiliates shall not be liable to the Company for any
claim arising out of, or based upon, (i) the investment by such Investor in any entity competitive with the Company, or (ii) actions
taken by any partner, officer or other representative of the Director or any of his affiliates to assist any such competitive company,
whether or not such action was taken as a member of the board of directors of such competitive company or otherwise, and whether
or not such action has a detrimental effect on the Company; provided, however, that the foregoing shall not relieve (x)
the Director from liability associated with the unauthorized disclosure of the Company’s confidential information obtained
pursuant to this Agreement, or (y) any director or officer of the Company from any liability associated with his or her fiduciary
duties to the Company.

 

Signature Page Follows

Remainder of page intentionally left
blank.

 

    	 	8	 

     

    

 

Signature Page to Independent Director's
Agreement

 

IN WITNESS WHEREOF,
the parties hereto have caused this Agreement to be duly executed and delivered as of the day and year first above written.

 

	 	 	FORM Holdings Corp.
	 	 	 
	 	 	 
	 	 	By:	 
	 	 	 	Name:
	 	 	 	Title:
	 	 	 	 
	 	 	 	 
	DIRECTOR	 	 	 
	 	 	 	 
	 	 	 	 

 

Andrew R. Heyer

 

    	 	9	 

     

    

 

 

EXHIBIT
A: INDEMNIFICATION AGREEMENT

 

[see
attached]

 

 

    	 	10	 

     

    

 

 

EXHIBIT
B: DIRECTOR'S ADDRESS

 

Andrew R. Heyer

c/o Mistral Capital Management, LLC

650 Fifth Avenue, 31st Floor

New York, NY 10019

Email: aheyer@mistralequity.com

 

With a copy (which shall not constitute
effective notice) to:

 

DLA Piper LLP (US)

1251 Avenue of the Americas

New York, NY 10020

Attention: Sidney Burke

Email: sidney.burke@dlapiper.com

 

 

    	 	11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00265-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00265-of-00352.parquet"}]]